Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02994953
Title A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Avelumab in Combination With M9241(NHS-IL12)
Acronym COMBO
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors EMD Serono
Indications
Therapies
Age Groups:
Covered Countries USA | NLD | ITA | HUN | FRA | ESP | BEL


No variant requirements are available.